Author:
Zhang Peng,Ye Guihua,Xie Guofeng,Lv Jie,Zeng Xianhai,Jiang Wei
Abstract
Cancer is one of the most lethal diseases in human society, and its incidence is gradually increasing. However, the current tumor treatment often meets the problem of poor efficacy and big side effects. The unique physical and chemical properties of nanomaterials can target the delivery of drugs to tumors, which can improve the therapeutic effect while reducing the damage of drugs to normal cells. This makes nanomaterials become a hot topic in the field of biomedicine. This review summarizes the recent progress of nanomaterials in tumor targeted therapy.
Subject
Biomedical Engineering,Histology,Bioengineering,Biotechnology
Reference73 articles.
1. Liposomal pegylated doxorubicin plus vinorelbine combination as first-line chemotherapy for metastatic breast cancer in elderly women ≥65 years of age;Addeo;Cancer Chemother. Pharmacol.,2008
2. Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles;Alavi;Drug Metab. Pers. Ther.,2019
3. Nanotechnology in ovarian cancer: Diagnosis and treatment;Barani;Life Sci.,2021
4. Two multicenter Phase I randomized trials to compare the bioequivalence and safety of a generic doxorubicin hydrochloride liposome injection with Doxil(®) or Caelyx(®) in advanced ovarian cancer;Bhowmik;Cancer Chemother. Pharmacol.,2018
5. Lignin, lipid, protein, hyaluronic acid, starch, cellulose, gum, pectin, alginate and chitosan-based nanomaterials for cancer nanotherapy: Challenges and opportunities;Carrion;Int. J. Biol. Macromol.,2021